Treatment and outcome of 82 patients with angiosarcoma.
Identifieur interne : 003727 ( PubMed/Curation ); précédent : 003726; suivant : 003728Treatment and outcome of 82 patients with angiosarcoma.
Auteurs : John A. Abraham [États-Unis] ; Francis J. Hornicek ; Adam M. Kaufman ; David C. Harmon ; Dempsey S. Springfield ; Kevin A. Raskin ; Henry J. Mankin ; David G. Kirsch ; Andrew E. Rosenberg ; G Petur Nielsen ; Vikram Desphpande ; Herman D. Suit ; Thomas F. Delaney ; Sam S. YoonSource :
- Annals of surgical oncology [ 1068-9265 ] ; 2007.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Femelle, Humains, Hémangiosarcome (), Hémangiosarcome (anatomopathologie), Mâle, Radiothérapie adjuvante, Résultat thérapeutique, Soins palliatifs, Stade de la tumeur, Sujet âgé, Sujet âgé de 80 ans ou plus, Survie sans rechute, Taux de survie, Traitement médicamenteux adjuvant, Traitement néoadjuvant, Tumeurs cutanées (), Tumeurs cutanées (anatomopathologie), Tumeurs des tissus mous (), Tumeurs des tissus mous (anatomopathologie), Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Tumeurs osseuses (), Tumeurs osseuses (anatomopathologie), Tumeurs radio-induites (), Tumeurs radio-induites (anatomopathologie), Études de suivi, Études rétrospectives.
- MESH :
- anatomopathologie : Hémangiosarcome, Tumeurs cutanées, Tumeurs des tissus mous, Tumeurs du sein, Tumeurs osseuses, Tumeurs radio-induites.
- Adulte, Adulte d'âge moyen, Femelle, Humains, Hémangiosarcome, Mâle, Radiothérapie adjuvante, Résultat thérapeutique, Soins palliatifs, Stade de la tumeur, Sujet âgé, Sujet âgé de 80 ans ou plus, Survie sans rechute, Taux de survie, Traitement médicamenteux adjuvant, Traitement néoadjuvant, Tumeurs cutanées, Tumeurs des tissus mous, Tumeurs du sein, Tumeurs osseuses, Tumeurs radio-induites, Études de suivi, Études rétrospectives.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Bone Neoplasms (pathology), Bone Neoplasms (surgery), Breast Neoplasms (pathology), Breast Neoplasms (surgery), Chemotherapy, Adjuvant, Disease-Free Survival, Female, Follow-Up Studies, Hemangiosarcoma (pathology), Hemangiosarcoma (surgery), Humans, Male, Middle Aged, Neoadjuvant Therapy, Neoplasm Staging, Neoplasms, Radiation-Induced (pathology), Neoplasms, Radiation-Induced (surgery), Palliative Care, Radiotherapy, Adjuvant, Retrospective Studies, Skin Neoplasms (pathology), Skin Neoplasms (surgery), Soft Tissue Neoplasms (pathology), Soft Tissue Neoplasms (surgery), Survival Rate, Treatment Outcome.
- MESH :
- pathology : Bone Neoplasms, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Radiation-Induced, Skin Neoplasms, Soft Tissue Neoplasms.
- surgery : Bone Neoplasms, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Radiation-Induced, Skin Neoplasms, Soft Tissue Neoplasms.
- Adult, Aged, Aged, 80 and over, Chemotherapy, Adjuvant, Disease-Free Survival, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neoadjuvant Therapy, Neoplasm Staging, Palliative Care, Radiotherapy, Adjuvant, Retrospective Studies, Survival Rate, Treatment Outcome.
Abstract
Angiosarcomas are an uncommon type of malignancy that are generally thought to behave usually in a locally aggressive fashion; they often metastasize to distant sites.
DOI: 10.1245/s10434-006-9335-y
PubMed: 17356953
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003727
Links to Exploration step
pubmed:17356953Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment and outcome of 82 patients with angiosarcoma.</title><author><name sortKey="Abraham, John A" sort="Abraham, John A" uniqKey="Abraham J" first="John A" last="Abraham">John A. Abraham</name><affiliation wicri:level="1"><nlm:affiliation>Orthopedic Oncology, Department of Orthopedics, Massachusetts General Hospital, Yawkey 7B-7926, 55 Fruit Street, Boston, Massachusetts 02114, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Orthopedic Oncology, Department of Orthopedics, Massachusetts General Hospital, Yawkey 7B-7926, 55 Fruit Street, Boston, Massachusetts 02114</wicri:regionArea></affiliation></author><author><name sortKey="Hornicek, Francis J" sort="Hornicek, Francis J" uniqKey="Hornicek F" first="Francis J" last="Hornicek">Francis J. Hornicek</name></author><author><name sortKey="Kaufman, Adam M" sort="Kaufman, Adam M" uniqKey="Kaufman A" first="Adam M" last="Kaufman">Adam M. Kaufman</name></author><author><name sortKey="Harmon, David C" sort="Harmon, David C" uniqKey="Harmon D" first="David C" last="Harmon">David C. Harmon</name></author><author><name sortKey="Springfield, Dempsey S" sort="Springfield, Dempsey S" uniqKey="Springfield D" first="Dempsey S" last="Springfield">Dempsey S. Springfield</name></author><author><name sortKey="Raskin, Kevin A" sort="Raskin, Kevin A" uniqKey="Raskin K" first="Kevin A" last="Raskin">Kevin A. Raskin</name></author><author><name sortKey="Mankin, Henry J" sort="Mankin, Henry J" uniqKey="Mankin H" first="Henry J" last="Mankin">Henry J. Mankin</name></author><author><name sortKey="Kirsch, David G" sort="Kirsch, David G" uniqKey="Kirsch D" first="David G" last="Kirsch">David G. Kirsch</name></author><author><name sortKey="Rosenberg, Andrew E" sort="Rosenberg, Andrew E" uniqKey="Rosenberg A" first="Andrew E" last="Rosenberg">Andrew E. Rosenberg</name></author><author><name sortKey="Nielsen, G Petur" sort="Nielsen, G Petur" uniqKey="Nielsen G" first="G Petur" last="Nielsen">G Petur Nielsen</name></author><author><name sortKey="Desphpande, Vikram" sort="Desphpande, Vikram" uniqKey="Desphpande V" first="Vikram" last="Desphpande">Vikram Desphpande</name></author><author><name sortKey="Suit, Herman D" sort="Suit, Herman D" uniqKey="Suit H" first="Herman D" last="Suit">Herman D. Suit</name></author><author><name sortKey="Delaney, Thomas F" sort="Delaney, Thomas F" uniqKey="Delaney T" first="Thomas F" last="Delaney">Thomas F. Delaney</name></author><author><name sortKey="Yoon, Sam S" sort="Yoon, Sam S" uniqKey="Yoon S" first="Sam S" last="Yoon">Sam S. Yoon</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:17356953</idno><idno type="pmid">17356953</idno><idno type="doi">10.1245/s10434-006-9335-y</idno><idno type="wicri:Area/PubMed/Corpus">003727</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003727</idno><idno type="wicri:Area/PubMed/Curation">003727</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003727</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Treatment and outcome of 82 patients with angiosarcoma.</title><author><name sortKey="Abraham, John A" sort="Abraham, John A" uniqKey="Abraham J" first="John A" last="Abraham">John A. Abraham</name><affiliation wicri:level="1"><nlm:affiliation>Orthopedic Oncology, Department of Orthopedics, Massachusetts General Hospital, Yawkey 7B-7926, 55 Fruit Street, Boston, Massachusetts 02114, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Orthopedic Oncology, Department of Orthopedics, Massachusetts General Hospital, Yawkey 7B-7926, 55 Fruit Street, Boston, Massachusetts 02114</wicri:regionArea></affiliation></author><author><name sortKey="Hornicek, Francis J" sort="Hornicek, Francis J" uniqKey="Hornicek F" first="Francis J" last="Hornicek">Francis J. Hornicek</name></author><author><name sortKey="Kaufman, Adam M" sort="Kaufman, Adam M" uniqKey="Kaufman A" first="Adam M" last="Kaufman">Adam M. Kaufman</name></author><author><name sortKey="Harmon, David C" sort="Harmon, David C" uniqKey="Harmon D" first="David C" last="Harmon">David C. Harmon</name></author><author><name sortKey="Springfield, Dempsey S" sort="Springfield, Dempsey S" uniqKey="Springfield D" first="Dempsey S" last="Springfield">Dempsey S. Springfield</name></author><author><name sortKey="Raskin, Kevin A" sort="Raskin, Kevin A" uniqKey="Raskin K" first="Kevin A" last="Raskin">Kevin A. Raskin</name></author><author><name sortKey="Mankin, Henry J" sort="Mankin, Henry J" uniqKey="Mankin H" first="Henry J" last="Mankin">Henry J. Mankin</name></author><author><name sortKey="Kirsch, David G" sort="Kirsch, David G" uniqKey="Kirsch D" first="David G" last="Kirsch">David G. Kirsch</name></author><author><name sortKey="Rosenberg, Andrew E" sort="Rosenberg, Andrew E" uniqKey="Rosenberg A" first="Andrew E" last="Rosenberg">Andrew E. Rosenberg</name></author><author><name sortKey="Nielsen, G Petur" sort="Nielsen, G Petur" uniqKey="Nielsen G" first="G Petur" last="Nielsen">G Petur Nielsen</name></author><author><name sortKey="Desphpande, Vikram" sort="Desphpande, Vikram" uniqKey="Desphpande V" first="Vikram" last="Desphpande">Vikram Desphpande</name></author><author><name sortKey="Suit, Herman D" sort="Suit, Herman D" uniqKey="Suit H" first="Herman D" last="Suit">Herman D. Suit</name></author><author><name sortKey="Delaney, Thomas F" sort="Delaney, Thomas F" uniqKey="Delaney T" first="Thomas F" last="Delaney">Thomas F. Delaney</name></author><author><name sortKey="Yoon, Sam S" sort="Yoon, Sam S" uniqKey="Yoon S" first="Sam S" last="Yoon">Sam S. Yoon</name></author></analytic><series><title level="j">Annals of surgical oncology</title><idno type="ISSN">1068-9265</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Bone Neoplasms (pathology)</term><term>Bone Neoplasms (surgery)</term><term>Breast Neoplasms (pathology)</term><term>Breast Neoplasms (surgery)</term><term>Chemotherapy, Adjuvant</term><term>Disease-Free Survival</term><term>Female</term><term>Follow-Up Studies</term><term>Hemangiosarcoma (pathology)</term><term>Hemangiosarcoma (surgery)</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Neoadjuvant Therapy</term><term>Neoplasm Staging</term><term>Neoplasms, Radiation-Induced (pathology)</term><term>Neoplasms, Radiation-Induced (surgery)</term><term>Palliative Care</term><term>Radiotherapy, Adjuvant</term><term>Retrospective Studies</term><term>Skin Neoplasms (pathology)</term><term>Skin Neoplasms (surgery)</term><term>Soft Tissue Neoplasms (pathology)</term><term>Soft Tissue Neoplasms (surgery)</term><term>Survival Rate</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Hémangiosarcome ()</term><term>Hémangiosarcome (anatomopathologie)</term><term>Mâle</term><term>Radiothérapie adjuvante</term><term>Résultat thérapeutique</term><term>Soins palliatifs</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Survie sans rechute</term><term>Taux de survie</term><term>Traitement médicamenteux adjuvant</term><term>Traitement néoadjuvant</term><term>Tumeurs cutanées ()</term><term>Tumeurs cutanées (anatomopathologie)</term><term>Tumeurs des tissus mous ()</term><term>Tumeurs des tissus mous (anatomopathologie)</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (anatomopathologie)</term><term>Tumeurs osseuses ()</term><term>Tumeurs osseuses (anatomopathologie)</term><term>Tumeurs radio-induites ()</term><term>Tumeurs radio-induites (anatomopathologie)</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Hémangiosarcome</term><term>Tumeurs cutanées</term><term>Tumeurs des tissus mous</term><term>Tumeurs du sein</term><term>Tumeurs osseuses</term><term>Tumeurs radio-induites</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Bone Neoplasms</term><term>Breast Neoplasms</term><term>Hemangiosarcoma</term><term>Neoplasms, Radiation-Induced</term><term>Skin Neoplasms</term><term>Soft Tissue Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Bone Neoplasms</term><term>Breast Neoplasms</term><term>Hemangiosarcoma</term><term>Neoplasms, Radiation-Induced</term><term>Skin Neoplasms</term><term>Soft Tissue Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Chemotherapy, Adjuvant</term><term>Disease-Free Survival</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Neoadjuvant Therapy</term><term>Neoplasm Staging</term><term>Palliative Care</term><term>Radiotherapy, Adjuvant</term><term>Retrospective Studies</term><term>Survival Rate</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Hémangiosarcome</term><term>Mâle</term><term>Radiothérapie adjuvante</term><term>Résultat thérapeutique</term><term>Soins palliatifs</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Survie sans rechute</term><term>Taux de survie</term><term>Traitement médicamenteux adjuvant</term><term>Traitement néoadjuvant</term><term>Tumeurs cutanées</term><term>Tumeurs des tissus mous</term><term>Tumeurs du sein</term><term>Tumeurs osseuses</term><term>Tumeurs radio-induites</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Angiosarcomas are an uncommon type of malignancy that are generally thought to behave usually in a locally aggressive fashion; they often metastasize to distant sites.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17356953</PMID><DateCreated><Year>2007</Year><Month>06</Month><Day>01</Day></DateCreated><DateCompleted><Year>2007</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2007</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1068-9265</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>6</Issue><PubDate><Year>2007</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Annals of surgical oncology</Title><ISOAbbreviation>Ann. Surg. Oncol.</ISOAbbreviation></Journal><ArticleTitle>Treatment and outcome of 82 patients with angiosarcoma.</ArticleTitle><Pagination><MedlinePgn>1953-67</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Angiosarcomas are an uncommon type of malignancy that are generally thought to behave usually in a locally aggressive fashion; they often metastasize to distant sites.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients with a diagnosis of angiosarcoma treated at our institution between 1980 and 2006 were analyzed for patient demographics, tumor characteristics, multimodality treatment, and outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 82 patients were divided into those with primary and advanced disease. Overall, the median age was 65 (range, 22-91) years, and 44% of patients were women. Median size of tumors was 3.8 cm, and 76% of tumors were intermediate or high grade. Tumors were located throughout the body: 32 cutaneous, 22 deep soft tissues or organs, 10 radiation or lymphedema field, 8 bone, and 7 nonirradiated breast. Of 46 patients with primary disease, all patients underwent surgical resection, 67% received radiotherapy, and 27% received chemotherapy. Five-year disease-specific survival was 60%, and negative prognostic factors included intermediate or high grade, and tumors arising in a radiated or lymphedema field. Of 36 patients with advanced disease, 36% underwent a palliative operation, 78% received radiation, and 58% received chemotherapy. Median survival was just 7.3 months, and cutaneous tumors predicted a better prognosis compared with other sites.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Primary angiosarcomas treated with aggressive surgical resection and the addition of radiation for close margins or worrisome pathologic features can result in long-term survival in most patients. The role of adjuvant chemotherapy is unclear. Patients with advanced disease have a poor prognosis, but there can be dramatic responses to chemotherapy in a minority of patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abraham</LastName><ForeName>John A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Orthopedic Oncology, Department of Orthopedics, Massachusetts General Hospital, Yawkey 7B-7926, 55 Fruit Street, Boston, Massachusetts 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hornicek</LastName><ForeName>Francis J</ForeName><Initials>FJ</Initials></Author><Author ValidYN="Y"><LastName>Kaufman</LastName><ForeName>Adam M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Harmon</LastName><ForeName>David C</ForeName><Initials>DC</Initials></Author><Author ValidYN="Y"><LastName>Springfield</LastName><ForeName>Dempsey S</ForeName><Initials>DS</Initials></Author><Author ValidYN="Y"><LastName>Raskin</LastName><ForeName>Kevin A</ForeName><Initials>KA</Initials></Author><Author ValidYN="Y"><LastName>Mankin</LastName><ForeName>Henry J</ForeName><Initials>HJ</Initials></Author><Author ValidYN="Y"><LastName>Kirsch</LastName><ForeName>David G</ForeName><Initials>DG</Initials></Author><Author ValidYN="Y"><LastName>Rosenberg</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>G Petur</ForeName><Initials>GP</Initials></Author><Author ValidYN="Y"><LastName>Desphpande</LastName><ForeName>Vikram</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Suit</LastName><ForeName>Herman D</ForeName><Initials>HD</Initials></Author><Author ValidYN="Y"><LastName>DeLaney</LastName><ForeName>Thomas F</ForeName><Initials>TF</Initials></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Sam S</ForeName><Initials>SS</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>5K12CA87723-03</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg Oncol</MedlineTA><NlmUniqueID>9420840</NlmUniqueID><ISSNLinking>1068-9265</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001859" MajorTopicYN="N">Bone Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006394" MajorTopicYN="N">Hemangiosarcoma</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020360" MajorTopicYN="N">Neoadjuvant Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009381" MajorTopicYN="N">Neoplasms, Radiation-Induced</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010166" MajorTopicYN="N">Palliative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018714" MajorTopicYN="N">Radiotherapy, Adjuvant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012983" MajorTopicYN="N">Soft Tissue Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>09</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>12</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>3</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>10</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>3</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17356953</ArticleId><ArticleId IdType="doi">10.1245/s10434-006-9335-y</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003727 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003727 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:17356953
|texte= Treatment and outcome of 82 patients with angiosarcoma.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:17356953" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |